Chao, MD, FACS, Co-Founder & Chief Medical Officer, VedaNu Wellness
Contact: Rebecca Alder +44 1983 866780 [email protected] 1 Ziemke F
[18] [19] The SURMOUNT-1 trial, which assessed tirzepatide for weight management, showed higher rates, with nausea affecting approximately 31% of participants at the 15 mg dose
An in-house Certificate of Analysis is published on the product page, and we routinely commission independent third-party testing on batches at random to confirm internal results
It is the experience that goes beyond food: the creation of the experience, the narrative and storytelling of the food experience, and the act of sharing that experience through service